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Abstract
We sought to i) identify putative genetic determinants of the severity of rheumatoid arthritis in the
NARAC (North American Rheumatoid Arthritis Consortium) data, ii) assess whether known
candidate genes for disease status are also associated with disease severity in those affected, and
iii) determine whether heterogeneity among the severity phenotypes can be explained by genetic
and/or host factors. These questions are addressed by developing bivariate mixed-counting process
models for numbers of tender and swollen joints to evaluate genetic association of candidate
polymorphisms, such as DRB1, and selected single-nucleotide polymorphisms in known candidate
genes/regions for rheumatoid arthritis, including PTPN22, and those in the regions identified by a
genome-wide linkage scan of disease severity using the dense Illumina single-nucleotide
polymorphism panel. The counting process framework provides a flexible approach to account for
the duration of rheumatoid arthritis, an attractive feature when modeling severity of a disease.
Moreover, we found a gain in efficiency when using a bivariate compared to a univariate counting
process model.
Background
The NARAC (North American Rheumatoid Arthritis Con-
sortium) data provided for Genetic Analysis Workshop 15
(GAW15) includes 757 families with 8017 individuals
representing multiple ethnicities. The data include infor-
mation on family relationships, discrete and quantitative
phenotypes, covariates, and genome-wide microsatellite
genotypes and single-nucleotide polymorphism (SNP)
genotypes from Illumina as well as genetic locations for
microsatellites and physical locations for SNPs [1].
Our data set for association analysis consists of informa-
tion on 1492 individuals in 710 families selected from the
NAPHENO data. Subjects were included only if informa-
tion on "TenderJtCt", "SwollenJtCt", "YrOnset", and
"YrAscer" are available. The severity phenotypes include
the joint count variables "TenderJtCt" and "SwollenJtCt".
When examined with respect to the duration of rheuma-
toid arthritis (RA) (calculated by subtracting "YrOnset"
from "YrAscer"), the joint variables can be viewed as a
bivariate counting process. Note that the observed time
from Genetic Analysis Workshop 15
St. Pete Beach, Florida, USA. 11–15 November 2006
Published: 18 December 2007
BMC Proceedings 2007, 1(Suppl 1):S120
<supplement> <title> <p>Genetic Analysis Workshop 15: Gene Expression Analysis and Approaches to Detecting Multiple Functional Loci</p> </title> <editor>Heather J Cordell, Mariza de Andrade, Marie-Claude Babron, Christopher W Bartlett, Joseph Beyene, Heike Bickeböller, Robert Culverhouse, Adrienne Cupples, E Warwick Daw, Josée Dupuis, Catherine T Falk, Saurabh Ghosh, Katrina A Goddard, Ellen L Goode, Elizabeth R Hauser, Lisa J Martin, Maria Martinez, Kari E North, Nancy L Saccone, Silke Schmidt, William Tapper, Duncan Thomas, David Tritchler, Veronica J Vieland, Ellen M Wijsman,  Marsha A Wilcox, John S Witte, Qiong Yang, Andreas Ziegler, Laura Almasy and Jean W MacCluer</editor> <note>Proceedings</note> <url>http://www.biomedcentral.com/content/pdf/1753-6561-1-S1-info.pdf</url> </supplement>
This article is available from: http://www.biomedcentral.com/1753-6561/1/S1/S120
© 2007 Sutradhar et al; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Proceedings 2007, 1(Suppl 1):S120 http://www.biomedcentral.com/1753-6561/1/S1/S120
Page 2 of 6
(page number not for citation purposes)
since RA onset varied from 1 to 72 years, and the number
of joints affected ranged from 0 to 28 and 0 to 26 for ten-
der and swollen, respectively.
Our analytic strategy consisted of the following steps. We
began by performing a genome-wide linkage scan using
the Illumina SNP panel to identify significant regions of
linkage for each count variable. Much of our attention
focused on chromosome 6, where a significant region of
linkage (harboring the HLA-DRB1 locus) has been previ-
ously reported for RA (disease status) [1]. The genome-
wide linkage analysis not only indicated regions that may
be fine-mapped via association analysis, but also sug-
gested differences in linkage signals between the count
phenotypes. This motivated the formulation of the bivar-
iate mixed-counting process framework that jointly mod-
eled both tender and swollen processes, as well as
detecting differences in patterns of association. We were
particularly interested in evaluating the genetic associa-
tion of candidate polymorphisms, such as DRB1, as well
as SNPs selected by genome-wide linkage analysis, or
within known candidate genes such as PTPN22, previ-
ously reported to be associated with an increased risk of
RA [2]. Due to restrictions on available software for link-
age analysis, the phenotypes were not modeled in the
same manner as for association analysis; the purpose of
the linkage analysis was simply to provide a preliminary
understanding of the linkage behavior and potential dif-
ferences between the tender and swollen joint count phe-
notypes.
Genome-wide linkage analysis with SNPs
A genome-wide linkage scan of the count variables availa-
ble in 1519 individuals in 710 families using 5744 SNPs
(Illumina panel) was performed via MERLIN-REGRESS
(version 1.0.1) [3], with the square root transformation of
the counts treated as quantitative traits. In this regression-
based method [4], we used the sample estimates of the
transformed counts as population means and variances,
and estimated heritability using the variance-components
(VC) option in MERLIN (version 1.0.1) [3], with values of
39% and 42% for transformed swollen and tender joint
counts, respectively. Because genetic maps were not avail-
able for the SNPs, we assumed that 1 Mb is equivalent to
1 cM.
Directing our attention to chromosome 6, which has been
previously reported to show a significant region of linkage
(harboring the HLA-DRB1 locus) for RA, we found two
regions of modest signal for each trait (see Fig. 1). One
region detected for both count variables spanned 26 to 33
Mb. A second region for the tender count variable
spanned 114 to 117 Mb, and a differing secondary region
for the swollen count variable spanned 155 to 158 Mb.
LOD score results from genome-wide linkage analysis Figure 1
LOD score results from genome-wide linkage analysis.BMC Proceedings 2007, 1(Suppl 1):S120 http://www.biomedcentral.com/1753-6561/1/S1/S120
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Several other regions of interest were also detected on
other chromosomes (Fig. 1). Adjusting this multipoint
analysis for linkage disequilibrium using MERLIN pro-
duced minor changes (Fig. 1).
Methods
A bivariate counting process model for genetic association 
of RA severity
Methods for analyzing data on events observed over time
have been of considerable interest in recent years. A
counting process framework [5,6] models count data, col-
lected at fixed points of ascertainment, by taking duration
of disease into consideration (as is the case in a cross-sec-
tional design, provided that the time of disease onset is
available). Under the assumption that the numbers of ten-
der and swollen joints do not decrease through time, we
have a recurrent event process.
Let {Nij(t), t ≥ 0} represent the underlying counting proc-
ess in which Nij(t) denotes the number of events experi-
enced by the jth process of the ith individual over the
continuous time interval (0, t], where i = 1,..., n. Note that
j = 1, 2 represents the tender and swollen joint counting
processes, respectively. Because it is reasonable to specify
a model that depends only on the current covariate values
rather than on the entire history process in our setting, we
formulated a non-homogeneous Poisson process. To han-
dle any substantial inter-individual variation in the
model, we introduced a positive individual-specific ran-
dom effect ui that is shared for both processes of the ith
subject. Conditional on ui, the counts of the ith subject are
independent. To be more specific, we assumed that condi-
tional on ui, the counting process {Nij(t), t ≥ 0} is a non-
homogeneous Poisson process with intensity and mean
functions represented as
λij (t|ui) = uiλ0j(t) exp{xij
Tβj}( 1 )
and
Λij (t|ui) = uiΛ0j(t) exp{xij
Tβj}, (2)
respectively. The time line is defined as the time since
onset of RA. The form of the intensity function is a relative
risk or Cox model, with the baseline intensity function for
the jth process λ0j(t) common among all subjects. The cov-
ariate vector xij, specific to the ith subject, may include can-
didate polymorphisms (such as DRB1), single SNPs
selected through genome-wide linkage scans, or a vector
of SNPs chosen to capture variation in a candidate gene or
candidate region (such as PTPN22); it may also include
characteristics such as sex and smoking history, or any
combination of reasonable interactions. The correspond-
ing regression parameter vector βj describes the associa-
tion of genotype with phenotype for the jth  process.
Furthermore, each individual has their own frailty ui act-
ing multiplicatively on the intensity function.
Unless the variance of the underlying mixing distribution
is exceptionally large, the gamma random effect provides
a robust approach for modeling mixed-Poisson processes
[7]. Assuming that u1,..., un are independent and identi-
cally distributed random variables arising from a gamma
distribution with mean of 1 and variance of φ, we obtain
the expectation E[Nij(t)] = E (E[Nij(t)|ui]) = Λ0j(t)
exp{xij
Tβj}, which represents the mean number of counts
for the jth process of the ith individual over the interval (0,
t]. The parameter φ is a measure of heterogeneity between
individuals that may not have been sufficiently accounted
for by the Poisson model alone. Larger values of φ imply
extra-Poisson variation in the model.
We now need to construct a likelihood function based on
our bivariate mixed-Poisson process assumptions. Sup-
pose the ith individual is ascertained at time τi, which is
relative to the time of onset. Conditional on the random
effect ui, the distribution of the counts P(Nij(τi) = nij|ui)
has a Poisson form. Moreover, under conditional inde-
pendence, the bivariate distribution of the counts can be
computed as P(ni1, ni2) = ∫ P(ni1, ni2|ui) dG(ui) = ∫ P(ni1|ui)
P(ni2|ui) g(ui) dui, which has a convenient closed form
expression due to the gamma-Poisson mixture. Thus the
log-likelihood log L(θ) = Σ log P(ni1, ni2) is maximized
with respect to θ, which consists of parameters β1, β2, φ,
and parameters of the baseline intensity functions. We
applied a Newton-Raphson technique, but any non-linear
maximization algorithm may be used for this purpose.
Furthermore, when maximizing the log-likelihood under
the counting process framework, it is most convenient to
assume a parametric form such as a Weibull model for the
baseline intensity functions, although semi-parametric
assumptions using piecewise constant models are also
reasonable alternatives.
In the case of a univariate counting process model, there
is no joint distribution formulated among the counts for
each individual. Rather, the log-likelihood is simply L(θ)
= ΣΣ log P(nij), where P(nij) = ∫ P(nij|ui) dG(ui) = ∫ P(nij|ui)
g(ui) dui.
Results and discussion
Association analysis of candidate gene DRB1
We applied our bivariate mixed-counting process model
for the severity phenotypes under various covariate mod-
els, yielding estimates and standard errors of β1, β2, and
log φ (Table 1). The asymptotic confidence interval for log
φ indicated a significant amount of extra-Poisson varia-
tion in the counts. That is, the number of tender joints var-
ied considerably between patients, as did the number of
swollen joints. The heterogeneity appeared to decrease asBMC Proceedings 2007, 1(Suppl 1):S120 http://www.biomedcentral.com/1753-6561/1/S1/S120
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more covariates were added to the model, and any
remaining variation in the model was captured under this
random effects formulation. The log-likelihood increased
dramatically as the covariates sex, smoking history, and
DRB1 were added to the model. The likelihood ratio (LR)
test for the joint contribution of sex to the bivariate model
(2 degrees of freedom) provided a p-value less than 1 × 10-
6, and the LR test for the joint contribution of DRB1 pro-
vided a p-value less than 0.0001. The Wald test detected a
significant sex effect for the tender, but not for the swollen
joint process. These sex differences were evident in plots
of the estimated mean number of counts (Fig. 2). The LR
test for the equality of DRB1 between the two counting
processes in the bivariate model (1 degree of freedom)
yielded a p-value less than 1 × 10-5.
Relative efficiency computations (not shown), obtained
by taking the ratio of the variances, suggested a gain in
information for the bivariate versus univariate counting
process model. For the tender and swollen outcomes, the
relative variance ranged from 1.122 to 1.294 and 1.005 to
1.015, respectively, under various covariates.
Association analysis of the 14 PTPN22 SNPs on 
chromosome 1 and 404 illumina SNPs on chromosome 6
To evaluate the genetic association of candidate gene
PTPN22 and SNPs on chromosome 6, we performed vari-
ous LR tests under both univariate and bivariate mixed-
counting process models. Under the univariate model we
tested
(i) Ho : βtender, SNP = 0 and (ii) Ho: βswollen, SNP = 0,
Table 1: Results under a bivariate mixed-counting process model for genetic association of RA severity
Covariate associations
Model log L Heterogeneity log φ (SE) Outcome Sex β (SE) Smoking history β (SE) DRB1 β (SE)
No covariates -10052.06 -0.358 (0.04) Tender
Swollen
With sex -10035.23 -0.360 (0.04) Tender -0.185 (0.05)
Swollen -0.010 (0.05)
With sex, -10031.06 -0.365 (0.04) Tender -0.216 (0.06) 0.139 (0.04)
smoking history Swollen -0.035 (0.05) 0.110 (0.04)
With sex, -10020.33 -0.366 (0.04) Tender -0.216 (0.06) 0.139 (0.05) -0.009 (0.03)
smoking history, and DRB1 Swollen -0.038 (0.06) 0.107 (0.05) 0.071 (0.03)
Estimated mean number of counts versus time since RA onset Figure 2
Estimated mean number of counts versus time since RA onset.BMC Proceedings 2007, 1(Suppl 1):S120 http://www.biomedcentral.com/1753-6561/1/S1/S120
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and under the bivariate model we tested
(i) Ho : βtender, SNP = 0, βswollen, SNP = 0 and (ii) Ho : βtender, SNP 
= βswollen, SNP.
Note that, along with sex and smoking history, DRB1 was
included in the model since it is significant based on the
results of the association analysis above, and also because
it has been previously reported to show strong linkage [1]
and association with RA. Figure 3 consists of plots of the
p-values for each SNP. The dashed line indicates a region-
wide Bonferroni significance criterion, computed as the
ratio of a selected significant p-value (0.05) over the
number of tests performed.
Conclusion
The counting process model examines phenotypes in a
longitudinal framework by taking duration of disease into
account. This model is applicable in a cross-sectional
design, provided that the time of disease onset is availa-
Likelihood ratio test p-values under univariate and bivariate models (with sex, smoking history, and DRB1) for SNPs on chro- mosome 1 and 6 Figure 3
Likelihood ratio test p-values under univariate and bivariate models (with sex, smoking history, and DRB1) for SNPs on chro-
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ble. Genetic association analysis under a bivariate model
provides a stronger approach than treating each outcome
separately. The use of the counting process to model RA
severity is novel, so our primary focus is the association
between the bivariate count phenotypes and main effects,
however an extension to incorporate gene × gene and gene
× environment interactions would be straightforward.
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